Cases

Search U.S. court opinions (CourtListener / Free Law Project), or resolve a reporter citation to its case via the Caselaw Access Project. Facts only — name, court, date, status, citation count. Never a holding-summary.

2 opinions for “In Re Chantix (Varenicline) Products Liability Litigation MDL 2092”

In Re Chantix (Varenicline) Products Liability Litigationpublic domain

United States Judicial Panel on Multidistrict Litigation · 2009-10-01 · Published · cited 1× · 655 F. Supp. 2d 1346; 2009 U.S. Dist. LEXIS 92169; 2009 WL 3163542

655 F.Supp.2d 1346 (2009) In re: CHANTIX (VARENICLINE) PRODUCTS LIABILITY LITIGATION. MDL No. 2092. United States Judicial Panel on Multidistrict Litigation. October 1, 2009. Before ROBERT L. MILLER, JR., Acting Chairman, JOHN G. HEYBURN II, Chairman[*], KATHRYN H. VRATIL, DAVID R. HANSEN, W. ROYAL FURGESON, JR. and FRANK C. DAMRELL, JR., Judges of the Panel.

read the full opinion · at the source · see the docket → · find the judge →

In re Testosterone Replacement Therapy Products Liability Litigationpublic domain

District Court, N.D. Illinois · 2016-03-07 · Published · cited 0× · 167 F. Supp. 3d 936; 2016 WL 929343

*937 CASE MANAGEMENT ORDER NO. 27 (CONTACT WITH PLAINTIFFS’ TREATING PHYSICIANS) MATTHEW F. KENNELLY, District Judge: Defendant AbbVie has asked the Court to impose restrictions on pre-deposition contacts between both plaintiffs’ and defendants’ counsel and the physicians who treated or prescribed medications for plaintiffs. Plaintiffs oppo

read the full opinion · at the source · see the docket → · find the judge →